THE COMMUNITY ONCOLOGY ALLIANCE and the Community Oncology Pharmacy Association appointed its advisory board. Josh Cox and Tommy Harwood will serve as advisory board co-chairs. Board members include: Steve D’Amato, executive director, New England Cancer Specialists John Clagg, director of pharmacy and admixture services, The Center for Cancer and Blood Disorders Josh Cox, director of... […]
THE BARBARA ANN KARMANOS CANCER INSTITUTE raised more than $2.8 million with its 33rd annual dinner, held at the General Motors Design Dome in Detroit.
FDA granted a Fast Track Designation for evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer. \
THE MARYLAND PROTON THERAPY CENTER completed its funding, through parties including Varian Medical Systems, Deutsche Bank AG, and several private investors.
ERIC LIU, a surgeon specializing in neuroendocrine tumors, will join Rocky Mountain Cancer Centers June 1.
Eli Lilly and Company and BioNTech AG entered into a research collaboration to discover novel cancer immunotherapies.
MD ANDERSON CANCER CENTER made several changes in its executive team.
LISA KACHNIC was named professor and chair of the Department of Radiation Oncology at Vanderbilt-Ingram Cancer Center. She will join the faculty on Sept. 21.
MICHAEL SIMON received the 2015 Blue Cross Blue Shield of Michigan Foundation McDevitt Excellence in Research Award for Physicians in the area of clinical research. Simon is leader of the Breast Cancer Multidisciplinary Team and co-leader of the Population Studies and Disparities Research Program at the Barbara Ann Karmanos Cancer Institute.
EDUARDO SOTOMAYOR was named inaugural director of the GW Cancer Center. He will also serve as a professor of medicine.
